Inventor · disambiguated record
Ahmed Abd Almalik Ahmed Mohammed Daak
Also filed as: DAAK AHMED · DAAK AHMED ABD ALMALIK AHMED MOHAMMED
2 granted patents·5 pending applications·0 citations·filing 2016–2025
33Inventor score
Technology areasA61K
Top patents by PatentIndex Score
7 records- 0167US10894027B2Sickle cell disease treatment utilizing omega-3 fatty acidsMICELLE BIOPHARMA INC·Filed 2019·Granted Jan 19, 2021·0 cites·1 claims
- 0260US2021322359A1Sickle cell disease treatment utilizing omega-3 fatty acidsMICELLE BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 0360US2025108054A1Methods for treating persistent or chronic immune thrombocytopenia in children, adolescents and adults by administering (r)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrilePRINCIPIA BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0460US2021322360A1Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease statesMICELLE BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 0557US10898458B2Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease statesMICELLE BIOPHARMA INC·Filed 2017·Granted Jan 26, 2021·0 cites·20 claims
- 0647US2025255874A1Methods for Treating Immune Thrombocytopenia By Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-EnentrilePRINCIPIA BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 0735US2016296492A1Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease statesSANCILIO & COMPANY INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ahmed Abd Almalik Ahmed Mohammed Daak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →